Search research articles
Contact Us
Filters
Showing results (541-550 of 576) with videos related to
Page
of 58
Sort By:
Human Brain Mapping
|
April 19, 2020
Changes in white matter fiber density and morphology across the adult lifespan: A cross-sectional fixel-based analysis
Shao Wei Choy, Epifanio Bagarinao, Hirohisa Watanabe, et al.
Annals of Neurology
|
August 22, 2019
GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy
Masaki Okubo, Hiroshi Doi, Ryoko Fukai, et al.
The Journal of Clinical Investigation
|
July 30, 2019
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
Kunihiko Araki, Amane Araki, Daiyu Honda, et al.
American Journal of Human Genetics
|
August 14, 2012
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement
Hiroyuki Ishiura, Wataru Sako, Mari Yoshida, et al.
Journal of the Neurological Sciences
|
July 18, 2016
Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J)
Yasuhiro Watanabe, Emma Beeldman, Joost Raaphorst, et al.
Nature Communications
|
January 26, 2020
YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology
Hikari Tanaka, Hidenori Homma, Kyota Fujita, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 13, 2013
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
Ryoichi Nakamura, Naoki Atsuta, Hazuki Watanabe, et al.
Brain : a Journal of Neurology
|
May 22, 2020
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation
Eiko N Minakawa, Helena Akiko Popiel, Masayoshi Tada, et al.
The Lancet. Neurology
|
August 10, 2010
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, et al.
The New England Journal of Medicine
|
September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Timothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Page
of 58
Search research articles
Search
Showing results (541-550 of 576) with videos related to
Sort By:
Page
of 58
Human Brain Mapping
|
April 19, 2020
Changes in white matter fiber density and morphology across the adult lifespan: A cross-sectional fixel-based analysis
Shao Wei Choy, Epifanio Bagarinao, Hirohisa Watanabe, et al.
Annals of Neurology
|
August 22, 2019
GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy
Masaki Okubo, Hiroshi Doi, Ryoko Fukai, et al.
The Journal of Clinical Investigation
|
July 30, 2019
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
Kunihiko Araki, Amane Araki, Daiyu Honda, et al.
American Journal of Human Genetics
|
August 14, 2012
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement
Hiroyuki Ishiura, Wataru Sako, Mari Yoshida, et al.
Journal of the Neurological Sciences
|
July 18, 2016
Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J)
Yasuhiro Watanabe, Emma Beeldman, Joost Raaphorst, et al.
Nature Communications
|
January 26, 2020
YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology
Hikari Tanaka, Hidenori Homma, Kyota Fujita, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 13, 2013
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
Ryoichi Nakamura, Naoki Atsuta, Hazuki Watanabe, et al.
Brain : a Journal of Neurology
|
May 22, 2020
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation
Eiko N Minakawa, Helena Akiko Popiel, Masayoshi Tada, et al.
The Lancet. Neurology
|
August 10, 2010
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, et al.
The New England Journal of Medicine
|
September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Timothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Page
of 58